Europace Advance Access originally published online on October 3, 2009
Europace 2009 11(11):1434-1439; doi:10.1093/europace/eup235
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
REVIEWS
Predicting future shocks in implantable cardioverter defibrillator recipients: the role of biomarkers
Department of Cardiology, University Hospital of Heraklion, Crete, Greece
Simple clinical and laboratory indexes have been identified as predictors of arrhythmic events in implantable cardioverter defibrillator patients. Biomarkers, which are playing a growing role in the prognosis and treatment of patients with heart failure, could provide an auxiliary tool in this context, given that their measurement is now easy and widely available.
Key Words: Implantable cardioverter defibrillator, Predictors of shocks, Biomarkers, Natriuretic peptides
* Corresponding author. Tel: +30 2810 392422, Fax: +30 2810 542055, Email: cardio{at}med.uoc.gr
Manuscript submitted 13 March 2009. Accepted after revision 3 August 2009.